Summary
This study examined the effects of a combined surgery of sleeve gastrectomy (SG) and modified jejunoileal bypass (JIB) on the body weight, food intake, and the plasma levels of active glucagon-like peptide-1 (GLP-1) and total ghrelin of rats. Rats were divided into 3 groups in terms of different surgical protocol: SG-JIB (n=12), SG (n=12), JIB (n=12) and sham surgery groups (n=10). In SG-JIB group, rats was subjected to sleeve gastrectomy and end to side anastomosis of part of the jejunum (25 cm from the ligament of Treitz) to the ileum 25 cm proximal to the cecum. The body weight and food intake were evaluated during 10 consecutive weeks postoperatively. The levels of active GLP-1 and total ghrelin in the plasma of the rats were measured by ELISA assay. The results showed that the SG-JIB treated rats relative to SG- or JIB-treated ones produced a sustained reduction in food intake and weight gain. The level of active GLP-1 was elevated and total ghrelin level decreased in SG-JIB-treated rats as compared with SG- or JIB-treated ones. It was concluded that SG-JIB could efficiently reduce the body weight and food intake, alter obesity-related hormone levels of the rats, indicating that SG-JIB may be potentially used for the treatment of obesity.
Similar content being viewed by others
References
Mattar SG. Lifting the unbearable weight of morbid obesity. Ann Surg, 2008,247(1):28–29
Cawley J, Rizzo JA, Haas K. Occupation-specific absenteeism costs associated with obesity and morbid obesity. J Occup Environ Med, 2007,49(12):1317–1324
Prentice AM. The emerging epidemic of obesity in developing countries. Int J Epidemiol, 2006,35(1):93–99
Safer DJ. Diet, behavior modification, and exercise: a review of obesity treatments from a long-term perspective. South Med J, 1991,84(12):1470–1474
Wadden TA, Butryn ML, Byrne KJ. Efficacy of lifestyle modification for long-term weight control. Obes Res, 2004,12(Suppl):151S–162S
Puzziferri N, Blankenship J, Wolfe BM. Surgical treatment of obesity. Endocrine, 2006,29(1):11–19
Buchwald H, Williams SE. Bariatric surgery worldwide 2003. Obes Surg, 2004,14(9):1157–1164
Christou NV, Sampalis JS, Liberman M, et al. Surgery decreases long-term mortality, morbidity, and health care use in morbidly obese patients. Ann Surg, 2004,240(3): 416–423
Steinert RE, Poller B, Castelli MC, et al. Oral administration of glucagon-like peptide 1 or peptide YY 3–36 affects food intake in healthy male subjects. Am J Clin Nutr, 2010,92(4):810–817
Ochner CN, Gibson C, Shanik M, et al. Changes in neurohormonal gut peptides following bariatric surgery. Int J Obes (Lond), 2011,35(2):153–166
Wren AM, Small CJ, Ward HL, et al. The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology, 2000,141(11):4325–4328
Cohen R, Uzzan B, Bihan H, et al. Ghrelin levels and sleeve gastrectomy in super-super-obesity. Obes Surg, 2005,15(7):1501–1512
Thomas S, Schauer P. Bariatric surgery and the gut hormone response. Nutr Clin Pract, 2010,25(2):175–182
Strader AD. Ileal transposition provides insight into the effectiveness of gastric bypass surgery. Physiol Behav, 2006,88(3):277–282
Holdstock C, Zethelius B, Sundbom M, et al. Postprandial changes in gut regulatory peptides in gastric bypass patients. Int J Obes (Lond), 2008,32(11):1640–1646
Patriti A, Facchiano E, Gullà N, et al. Gut hormone profiles following bariatric surgery favor an anorectic state, facilitate weight loss, and improve metabolic parameters. Ann Surg, 2007,245(1):157–158
Frezza EE, Chiriva-Internati M, Wachtel MS. Analysis of the results of sleeve gastrectomy for morbid obesity and the role of ghrelin. Surg Today, 2008,38(6):481–483
Wang Y, Liu J. Plasma ghrelin modulation in gastric band operation and sleeve gastrectomy. Obes Surg, 2009,19(3): 357–362
Himpens J, Dapri G, Cadière GB. A prospective randomized study between laparoscopic gastric banding and laparoscopic isolated sleeve gastrectomy: results after 1 and 3 years. Obes Surg, 2006,16(11):1450–1456
Moon Han S, Kim WW, Oh JH. Results of laparoscopic sleeve gastrectomy (LSG) at 1 year in morbidly obese Korean patients. Obes Surg, 2005,15(10):1469–1475
Langer FB, Reza Hoda MA, Bohdjalian A, et al. Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels. Obes Surg, 2005,15(7):1024–1029
Micheletto G, Badiali M, Danelli PG, et al. The biliointestinal bypass: a thirty-year experience. Ann Ital Chir, 2008,79(6):419–426
Cleator IG, Polyakov G, Birmingham CL. Ileogastrostomy or jejunoileal bypass with drainage of the bypassed bowel into the stomach. Eur J Gastroenterol Hepatol, 1999,11(2):85–88
Dell’Anna B, Zannoni M, De Lorenzis G. Changes in the principal biohumoral parameters after jejuno-ileal bypass in rats with experimentally induced obesity. Acta Biomed Ateneo Parmense, 1982,53(2):51–58
Våge V, Solhaug JH, Berstad A, et al. Jejunoileal bypass in the treatment of morbid obesity: a 25-year follow-up study of 36 patients. Obes Surg, 2002,12(3):312–318
Frezza EE, Chiriva-Internati M. Analysis of the results of sleeve gastrectomy for morbid obesity and the role of ghrelin. Surg Today, 2008,38(6):481–483
Pournaras DJ, Le Roux CW. The effect of bariatric surgery on gut hormones that alter appetite. Diabetes Metab, 2009,35(6 pt 2):508–512
Pournaras DJ, Osborne A, Hawkins SC, et al. The gut hormone response following Roux-en-Y gastric bypass: cross-sectional and prospective study. Obes Surg, 2010,20(1):56–60
Näslund E, Grybäck P, Hellström PM, et al. Gastrointestinal hormones and gastric emptying 20 years after jejunoileal bypass for massive obesity. Int J Obes Relat Metab Disord, 1997,21(5):387–392
Alvarez Bartolomé M, Borque M, Martinez-Sarmiento J, et al. Peptide YY secretion in morbidly obese patients before and after vertical banded gastroplasty. Obes Surg, 2002,12(3):324–327
Doucet E. Gastrointestinal peptides after bariatric surgery and appetite control: are they in tuning? Curr Opin Clin Nutr Metab Care, 2008,11(5): 645–650
Borg CM, le Roux CW, Ghatei MA, et al. Biliopancreatic diversion in rats is associated with intestinal hypertrophy and with increased GLP-1, GLP-2 and PYY levels. Obes Surg, 2007,17(9):1193–1198
Reinehr T, Roth CL, Schernthaner GH, et al. Peptide YY and glucagon-like peptide-1 in morbidly obese patients before and after surgically induced weight loss. Obes Surg, 2007,17(12):1571–1577
Borg CM, le Roux CW, Ghatei MA, et al. Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg, 2006,93(2):210–215
Author information
Authors and Affiliations
Corresponding author
Additional information
The study was supported by a grant from Wuhan Municipal Science and Technology Key Project (201060938360-07).
Rights and permissions
About this article
Cite this article
Yan, L., Zhu, Z., Wu, D. et al. Effects of sleeve gastrectomy surgery with modified jejunoileal bypass on body weight, food intake and metabolic hormone levels of rats. J. Huazhong Univ. Sci. Technol. [Med. Sci.] 31, 784–788 (2011). https://doi.org/10.1007/s11596-011-0677-8
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-011-0677-8